AIP siRNA (Mouse)

Référence MBS829321-15nmol

Conditionnement : 15nmol

Marque : MyBiosource

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

AIP siRNA – Ah Receptor-Interacting Protein (Mouse)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS829321

MBS829321 is an siRNA targeting AIP. Also known as AIP siRNA (Mouse). Reactive in Mouse. Host: Synthetic. siRNA to inhibit AIP expression using RNA interference More details

Product Overview

Online Datasheet in PDF
Product Name
AIP, siRNA
Full Product Name
AIP siRNA (Mouse)
Product Gene Name
AIP sirna
Product Synonym Names
AH receptor-interacting protein; AIP; Aryl-hydrocarbon receptor-interacting protein
Host
Synthetic
Species Reactivity
Mouse
Form/Format
Lyophilized powder
Purity/Purification
> 97%
Specificity
AIP siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Molecular Weight
37,605 Da
3D Structure
ModBase 3D Structure for O08915
Negative Control
siRNA Negative Control (Catalog# MBS8241404) is a non-targeting 21 nt siRNA recommended as a negative control for experiments using targeted siRNA transfection.
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of mouse AIP gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Applications Tested/Suitable for AIP sirna
RNA Interference (RNAi)

Other Notes

Small volumes of AIP sirna vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for AIP. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
AH receptor-interacting protein
NCBI Official Synonym Full Names
aryl-hydrocarbon receptor-interacting protein
NCBI Official Symbol
Aip
NCBI Official Synonym Symbols
Ara9; Xap2; Fkbp16; AA408703; AW476050; D19Bwg1412e
UniProt Protein Name
AH receptor-interacting protein
UniProt Synonym Protein Names
Aryl-hydrocarbon receptor-interacting protein
Protein Family
AH receptor-interacting protein
UniProt Gene Name
Aip
UniProt Synonym Gene Names
AIP
UniProt Entry Name
AIP_MOUSE
NCBI Protein Information
AH receptor-interacting protein

NCBI Summary for AIP

This gene encodes an Hsp90-associated protein that is localized to the cytoplasm. The encoded protein interacts with the aryl hydrocarbon receptor (AhR) and the tyrosine kinase receptor RET, inhibits AhR ubiquitination, and regulates the intracellular localization of AhR. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Show more

UniProt Comments for AIP

AIP: May play a positive role in AHR-mediated (aromatic hydrocarbon receptor) signaling, possibly by influencing its receptivity for ligand and/or its nuclear targeting. Defects in AIP are a cause of growth hormone-secreting pituitary adenoma (GHSPA); also known as familial isolated somatotropinomas (FIS) or isolated familial somatotropinoma (IFS) or familial somatotrophinoma or acromegaly due to pituitary adenoma. Defects in AIP are a cause of ACTH-secreting pituitary adenoma (ASPA); also known as pituitary Cushing disease. A pituary adenoma resulting in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and trunkal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. Defects in AIP are a cause of prolactin-secreting pituitary adenoma (PSPA); also known as prolactinoma. Prolactin-secreting pituitary adenoma is the most common type of hormonally active pituitary adenoma.

Protein type: Nuclear receptor co-regulator; Transcription, coactivator/corepressor

Cellular Component: nucleoplasm; membrane; cytoplasm; plasma membrane; cytosol

Molecular Function: protein binding; aryl hydrocarbon receptor binding; unfolded protein binding; transcription cofactor activity

Biological Process: protein maturation via protein folding; protein folding; xenobiotic metabolic process; protein targeting to mitochondrion; negative regulation of cyclic-nucleotide phosphodiesterase activity
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with AIP sirna

 Reference Product  PubMed Publications
 Ahr sirna  >28 publications with AIP and Ahr
 Arnt sirna  >13 publications with AIP and Arnt
 Ret sirna  >8 publications with AIP and Ret
 Ahrr sirna  >5 publications with AIP and Ahrr
 Nub1 sirna  >2 publications with AIP and Nub1
 Hsp90aa1 sirna  >1 publications with AIP and Hsp90aa1

Diseases associated with AIP sirna

 Disease Name  Pubmed Publications
 Liver Diseases Antibodies  >348 publications with AIP and Liver Diseases
 Fibrosis Antibodies  >214 publications with AIP and Fibrosis
 Adenoma Antibodies  >122 publications with AIP and Adenoma
 Inflammation Antibodies  >103 publications with AIP and Inflammation
 Kidney Diseases Antibodies  >63 publications with AIP and Kidney Diseases
 Heart Diseases Antibodies  >42 publications with AIP and Heart Diseases
 Growth Hormone-Secreting Pituitary Adenoma Antibodies  >40 publications with AIP and Growth Hormone-Secreting Pituitary Adenoma
 Necrosis Antibodies  >36 publications with AIP and Necrosis
 Intestinal Diseases Antibodies  >36 publications with AIP and Intestinal Diseases
 Poisoning Antibodies  >36 publications with AIP and Poisoning

Organs/Tissues associated with AIP sirna

 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >572 publications with AIP and Blood
 Pancreas Antibodies  >379 publications with AIP and Pancreas
 Liver Antibodies  >219 publications with AIP and Liver
 Brain Antibodies  >212 publications with AIP and Brain
 Lung Antibodies  >132 publications with AIP and Lung
 Muscle Antibodies  >87 publications with AIP and Muscle
 Kidney Antibodies  >81 publications with AIP and Kidney
 Heart Antibodies  >73 publications with AIP and Heart
 Bone Antibodies  >39 publications with AIP and Bone
 Eye Antibodies  >35 publications with AIP and Eye